Armstrong Armatemp Cement No. 10

Product Description

Armstrong Armatemp Cement No. 10 was an industrial insulating cement manufactured by Armstrong World Industries between 1961 and 1972. Designed for high-temperature applications in industrial environments, the product was formulated to be applied directly to pipes, boilers, vessels, and other equipment where thermal insulation was essential to operations. As a trowel-applied or hand-mixed cement, Armatemp No. 10 was used in settings where machinery and piping systems were subjected to extreme heat, and where maintaining insulation integrity was critical to both efficiency and safety.

Armstrong World Industries, headquartered in Lancaster, Pennsylvania, was one of the largest manufacturers of building and industrial materials in the United States throughout the twentieth century. The company produced a wide range of insulating materials, adhesives, and construction products, many of which were sold into commercial, industrial, and shipbuilding markets. Armatemp Cement No. 10 represented part of Armstrong’s broader line of industrial cements intended for professional installation by tradespeople and industrial workers in manufacturing plants, refineries, power generation facilities, and similar heavy-use environments.

The product was sold and distributed during a period when asbestos was widely used in industrial insulation products, and when federal regulations governing asbestos exposure in the workplace had not yet been established. It was not until the early 1970s that the Occupational Safety and Health Administration (OSHA) began issuing enforceable standards for asbestos exposure, and OSHA’s first permissible exposure limit for asbestos was promulgated in 1971. Armstrong’s production of Armatemp Cement No. 10 spans almost precisely the period before those initial regulatory protections took effect.

Asbestos Content

Armstrong Armatemp Cement No. 10 contained chrysotile asbestos as a component of its formulation. Chrysotile, sometimes referred to as white asbestos, is the most commercially prevalent form of asbestos and belongs to the serpentine mineral group. Despite its different fiber structure compared to amphibole varieties such as amosite or crocidolite, chrysotile has been classified as a known human carcinogen by the International Agency for Research on Cancer (IARC), the U.S. Department of Health and Human Services, and the Environmental Protection Agency (EPA).

In industrial cement products of this type, chrysotile asbestos served as a reinforcing agent that improved the structural integrity of the cured cement, enhanced its resistance to thermal cycling, and helped the material adhere to curved or irregular surfaces such as pipe fittings and valve bodies. These functional properties made asbestos an attractive additive for manufacturers throughout the mid-twentieth century. However, the same fibrous quality that made chrysotile useful in manufacturing also made it hazardous when disturbed, as the fine mineral fibers can become airborne and, if inhaled, lodge permanently in lung tissue.

The Asbestos Hazard Emergency Response Act (AHERA) and subsequent EPA guidance have affirmed that no level of asbestos fiber exposure can be considered entirely safe, and that cumulative exposure over time increases the risk of asbestos-related disease, including mesothelioma, asbestosis, and lung cancer.

How Workers Were Exposed

Industrial workers who handled, mixed, or applied Armstrong Armatemp Cement No. 10 faced potential exposure to airborne chrysotile asbestos fibers during normal use of the product. Because the cement was intended for trowel application, workers would have mixed dry or semi-dry formulations, spread the material onto pipe surfaces, and trimmed or shaped the cured cement—all activities that could release respirable asbestos fibers into the surrounding air.

The mixing process posed a particular risk. When dry insulating cement is combined with water or disturbed in its powder form, the agitation can release significant concentrations of asbestos fibers into the breathing zone of workers in the immediate vicinity. Similarly, cutting or shaping cured cement that contained asbestos—whether to fit around pipe joints, flanges, or valves—could fracture the bonded material and release fibers that had been locked within the hardened matrix.

Industrial workers in refineries, chemical plants, steel mills, and power generation facilities were among those most likely to have worked with products like Armatemp Cement No. 10 during the 1961–1972 production window. In many industrial settings of that era, work was performed in enclosed or poorly ventilated spaces, which would have concentrated any airborne fibers and increased the duration and intensity of worker exposure. Respirators and other personal protective equipment were not consistently provided or required during much of this period.

Bystander exposure was also a documented concern in industrial environments, where workers in adjacent trades—pipefitters, boilermakers, millwrights, and laborers—could have inhaled fibers dislodged by workers actively applying or finishing insulating cements nearby. The invisible and odorless nature of asbestos fibers meant that workers had no sensory indication of exposure at the time.

Diseases associated with asbestos inhalation, including malignant mesothelioma, typically have a latency period of 20 to 50 years, meaning individuals exposed to Armatemp Cement No. 10 during the 1960s and early 1970s may not have received diagnoses until decades later.

Armstrong Armatemp Cement No. 10 is a Tier 2 product, meaning it has been the subject of civil litigation rather than a dedicated asbestos bankruptcy trust. No Armstrong World Industries asbestos trust currently administers claims specifically tied to Armatemp Cement No. 10 in an open filing posture applicable to all claimants. Individuals seeking compensation for asbestos-related illness associated with this product should consult with a qualified asbestos litigation attorney to evaluate their legal options.

Litigation records document that Armstrong World Industries faced asbestos-related lawsuits from industrial workers and their families over many years. Plaintiffs alleged that Armstrong knew or should have known about the hazards of asbestos-containing products and failed to provide adequate warnings to workers who used those products. Plaintiffs further alleged that this failure to warn deprived workers of the ability to protect themselves from exposure, contributing to serious and often fatal illness.

Litigation records also document claims involving industrial insulating cements as part of broader multi-product cases, where plaintiffs alleged exposure to asbestos from multiple manufacturers and product lines encountered over the course of a working career. In such cases, legal counsel typically conducts an occupational exposure history to identify all potentially responsible parties, which may include manufacturers, distributors, premises owners, and contractors.

Asbestos litigation remains active in many state and federal jurisdictions. Workers diagnosed with mesothelioma, asbestosis, lung cancer, or other asbestos-related conditions, as well as their surviving family members, may be eligible to pursue claims through direct civil litigation. Statutes of limitations for asbestos claims vary by state and generally begin running at the time of diagnosis rather than at the time of exposure, but prompt legal consultation is strongly advised.

Those who believe they were exposed to Armstrong Armatemp Cement No. 10 should document their employment history, work sites, and any known product interactions, as this information will be essential to any legal proceeding.